Concepts (430)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Dialysis | 30 | 2022 | 189 | 5.560 |
Why?
|
| Ascorbic Acid | 15 | 2020 | 46 | 3.700 |
Why?
|
| Kidney Failure, Chronic | 13 | 2020 | 206 | 2.700 |
Why?
|
| Ascorbic Acid Deficiency | 7 | 2014 | 7 | 2.060 |
Why?
|
| Hemoglobins | 6 | 2016 | 133 | 1.720 |
Why?
|
| Dialysis Solutions | 4 | 2015 | 6 | 1.290 |
Why?
|
| Anemia | 4 | 2011 | 119 | 1.080 |
Why?
|
| Chromatography, High Pressure Liquid | 19 | 2020 | 225 | 1.010 |
Why?
|
| Vitamins | 6 | 2023 | 74 | 0.880 |
Why?
|
| Oxidative Stress | 7 | 2003 | 279 | 0.830 |
Why?
|
| Carotenoids | 12 | 2006 | 66 | 0.800 |
Why?
|
| Dietary Supplements | 7 | 2023 | 223 | 0.790 |
Why?
|
| Macular Pigment | 1 | 2021 | 2 | 0.760 |
Why?
|
| Uremia | 3 | 2019 | 9 | 0.700 |
Why?
|
| Peritoneal Dialysis | 5 | 2012 | 14 | 0.690 |
Why?
|
| Antioxidants | 9 | 2006 | 241 | 0.670 |
Why?
|
| Indican | 2 | 2019 | 3 | 0.650 |
Why?
|
| Vitamin E | 13 | 2003 | 52 | 0.650 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 788 | 0.620 |
Why?
|
| Humans | 79 | 2023 | 59360 | 0.580 |
Why?
|
| Toxins, Biological | 2 | 2016 | 6 | 0.540 |
Why?
|
| beta Carotene | 10 | 2001 | 64 | 0.540 |
Why?
|
| Dialysis | 1 | 2016 | 8 | 0.520 |
Why?
|
| Erythrocytes | 2 | 2016 | 146 | 0.520 |
Why?
|
| Hospitalization | 2 | 2014 | 1290 | 0.520 |
Why?
|
| Serum Albumin | 1 | 2016 | 45 | 0.510 |
Why?
|
| Fatty Acids | 5 | 2009 | 190 | 0.460 |
Why?
|
| Membranes, Artificial | 1 | 2014 | 45 | 0.450 |
Why?
|
| Hyperoxaluria | 2 | 2020 | 8 | 0.450 |
Why?
|
| Oxalates | 3 | 2020 | 17 | 0.450 |
Why?
|
| Lipoproteins, LDL | 4 | 2004 | 45 | 0.440 |
Why?
|
| Fatigue | 3 | 2017 | 103 | 0.440 |
Why?
|
| Vitamin A | 7 | 2001 | 26 | 0.440 |
Why?
|
| Kidney Diseases | 3 | 2010 | 169 | 0.430 |
Why?
|
| DNA, Single-Stranded | 1 | 2014 | 100 | 0.430 |
Why?
|
| Hypercholesterolemia | 3 | 2004 | 68 | 0.400 |
Why?
|
| Hemodiafiltration | 2 | 2009 | 3 | 0.380 |
Why?
|
| Cholesterol, LDL | 4 | 2006 | 102 | 0.370 |
Why?
|
| Lutein | 7 | 2006 | 22 | 0.370 |
Why?
|
| Chromatography, Gas | 2 | 2009 | 8 | 0.370 |
Why?
|
| Insulin | 2 | 2009 | 674 | 0.360 |
Why?
|
| Dinoprost | 2 | 2001 | 19 | 0.360 |
Why?
|
| Erythrocyte Aging | 1 | 2010 | 2 | 0.360 |
Why?
|
| Male | 42 | 2022 | 27739 | 0.350 |
Why?
|
| Cholesterol | 7 | 2006 | 252 | 0.350 |
Why?
|
| Malnutrition | 1 | 2011 | 40 | 0.350 |
Why?
|
| Diet | 6 | 2014 | 497 | 0.340 |
Why?
|
| Xanthophylls | 9 | 2009 | 22 | 0.340 |
Why?
|
| Postprandial Period | 1 | 2009 | 18 | 0.330 |
Why?
|
| Iron | 2 | 2008 | 136 | 0.330 |
Why?
|
| Hypochlorous Acid | 2 | 2000 | 3 | 0.330 |
Why?
|
| Salmon | 1 | 2009 | 8 | 0.320 |
Why?
|
| Fingers | 1 | 2009 | 43 | 0.320 |
Why?
|
| Animals, Domestic | 1 | 2009 | 13 | 0.320 |
Why?
|
| Animals, Wild | 1 | 2009 | 10 | 0.320 |
Why?
|
| Needles | 1 | 2009 | 65 | 0.310 |
Why?
|
| Breath Tests | 3 | 2003 | 14 | 0.310 |
Why?
|
| Eating | 1 | 2009 | 130 | 0.310 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2008 | 5 | 0.300 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2008 | 5 | 0.300 |
Why?
|
| Middle Aged | 27 | 2019 | 16317 | 0.290 |
Why?
|
| Sodium, Dietary | 1 | 2007 | 9 | 0.290 |
Why?
|
| Ferric Compounds | 1 | 2007 | 38 | 0.290 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 259 | 0.280 |
Why?
|
| Sodium | 1 | 2007 | 60 | 0.280 |
Why?
|
| Macula Lutea | 5 | 2006 | 21 | 0.280 |
Why?
|
| Water | 1 | 2009 | 300 | 0.270 |
Why?
|
| Blood Glucose | 1 | 2009 | 461 | 0.270 |
Why?
|
| Female | 30 | 2022 | 30705 | 0.270 |
Why?
|
| Renal Replacement Therapy | 1 | 2006 | 22 | 0.270 |
Why?
|
| Ethane | 2 | 2003 | 2 | 0.260 |
Why?
|
| Aged | 18 | 2023 | 13416 | 0.260 |
Why?
|
| Reactive Oxygen Species | 3 | 2003 | 205 | 0.260 |
Why?
|
| Carnitine | 1 | 2006 | 18 | 0.260 |
Why?
|
| Vitamin B Complex | 1 | 2006 | 15 | 0.250 |
Why?
|
| Cresols | 2 | 2019 | 5 | 0.250 |
Why?
|
| Sulfuric Acid Esters | 2 | 2019 | 6 | 0.250 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2001 | 41 | 0.250 |
Why?
|
| Hypotension | 1 | 2006 | 48 | 0.250 |
Why?
|
| Dietary Fats | 2 | 2004 | 173 | 0.230 |
Why?
|
| Erythropoietin | 3 | 2010 | 35 | 0.220 |
Why?
|
| Adipose Tissue | 3 | 2009 | 283 | 0.220 |
Why?
|
| Cross-Sectional Studies | 5 | 2017 | 2373 | 0.220 |
Why?
|
| Cholesterol, HDL | 3 | 2006 | 71 | 0.220 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 114 | 0.220 |
Why?
|
| Adult | 22 | 2019 | 15669 | 0.210 |
Why?
|
| Diuretics | 1 | 2023 | 59 | 0.210 |
Why?
|
| Protein Binding | 3 | 2019 | 1557 | 0.210 |
Why?
|
| Kinetics | 8 | 2016 | 751 | 0.200 |
Why?
|
| Egg Yolk | 3 | 2006 | 6 | 0.200 |
Why?
|
| In Vitro Techniques | 4 | 2016 | 471 | 0.200 |
Why?
|
| Amino Acids | 2 | 2000 | 140 | 0.200 |
Why?
|
| Hypertension | 1 | 2007 | 568 | 0.190 |
Why?
|
| Oxidation-Reduction | 9 | 2000 | 302 | 0.190 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2001 | 19 | 0.190 |
Why?
|
| CD36 Antigens | 1 | 2021 | 26 | 0.190 |
Why?
|
| Child | 5 | 2021 | 4174 | 0.190 |
Why?
|
| Analytic Sample Preparation Methods | 1 | 2020 | 4 | 0.170 |
Why?
|
| Lipid Peroxides | 2 | 1999 | 11 | 0.170 |
Why?
|
| Nucleoside Diphosphate Sugars | 1 | 2020 | 2 | 0.170 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2020 | 5 | 0.170 |
Why?
|
| Lysine | 1 | 2000 | 75 | 0.170 |
Why?
|
| Acute Kidney Injury | 2 | 2012 | 132 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2000 | 128 | 0.170 |
Why?
|
| Free Radical Scavengers | 1 | 1999 | 18 | 0.170 |
Why?
|
| Avena | 1 | 1999 | 7 | 0.170 |
Why?
|
| Cognition | 1 | 2023 | 455 | 0.160 |
Why?
|
| Plants, Toxic | 2 | 1996 | 13 | 0.160 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2010 | 20 | 0.160 |
Why?
|
| Smoke | 2 | 1996 | 23 | 0.160 |
Why?
|
| Binding, Competitive | 2 | 2019 | 98 | 0.160 |
Why?
|
| Serum Albumin, Human | 1 | 2019 | 6 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 439 | 0.160 |
Why?
|
| Diabetes Mellitus | 2 | 2003 | 515 | 0.160 |
Why?
|
| Ibuprofen | 1 | 2019 | 18 | 0.160 |
Why?
|
| Smoking | 3 | 2001 | 826 | 0.160 |
Why?
|
| Animals | 20 | 2020 | 19651 | 0.160 |
Why?
|
| Polysaccharides | 1 | 2020 | 141 | 0.150 |
Why?
|
| Retina | 6 | 1992 | 115 | 0.150 |
Why?
|
| Kynurenine | 1 | 2017 | 6 | 0.140 |
Why?
|
| Inflammation | 4 | 2009 | 1099 | 0.140 |
Why?
|
| Chronic Disease | 3 | 2010 | 716 | 0.140 |
Why?
|
| Leg | 2 | 2022 | 85 | 0.140 |
Why?
|
| Treatment Outcome | 6 | 2019 | 5284 | 0.140 |
Why?
|
| Tryptophan | 1 | 2017 | 54 | 0.140 |
Why?
|
| Eggs | 2 | 2006 | 7 | 0.140 |
Why?
|
| Lipids | 4 | 2006 | 300 | 0.130 |
Why?
|
| Erythropoiesis | 2 | 2006 | 35 | 0.130 |
Why?
|
| Zeaxanthins | 7 | 2006 | 14 | 0.130 |
Why?
|
| Electric Impedance | 2 | 2022 | 35 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 839 | 0.120 |
Why?
|
| Diabetes Complications | 2 | 2014 | 100 | 0.120 |
Why?
|
| Albumins | 1 | 2015 | 34 | 0.120 |
Why?
|
| Retinal Pigments | 3 | 1991 | 5 | 0.120 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 689 | 0.120 |
Why?
|
| Heart Failure | 1 | 2022 | 853 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2019 | 3067 | 0.110 |
Why?
|
| Sleep | 1 | 2017 | 215 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2014 | 5128 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2017 | 1051 | 0.110 |
Why?
|
| Cattle | 3 | 2007 | 304 | 0.110 |
Why?
|
| C-Reactive Protein | 3 | 2003 | 159 | 0.100 |
Why?
|
| Prognosis | 2 | 2008 | 1600 | 0.100 |
Why?
|
| Nutritional Status | 4 | 2009 | 93 | 0.100 |
Why?
|
| Reference Standards | 4 | 2009 | 71 | 0.100 |
Why?
|
| Stereoisomerism | 4 | 2009 | 68 | 0.100 |
Why?
|
| Muscles | 2 | 2009 | 173 | 0.100 |
Why?
|
| F2-Isoprostanes | 2 | 2001 | 4 | 0.100 |
Why?
|
| Hospital Administration | 1 | 2012 | 41 | 0.090 |
Why?
|
| Cultural Competency | 1 | 2011 | 47 | 0.090 |
Why?
|
| Dielectric Spectroscopy | 1 | 2011 | 3 | 0.090 |
Why?
|
| Body Water | 1 | 2011 | 16 | 0.090 |
Why?
|
| Selenium | 2 | 1989 | 25 | 0.090 |
Why?
|
| Mass Spectrometry | 3 | 2000 | 295 | 0.090 |
Why?
|
| Developing Countries | 1 | 2012 | 85 | 0.090 |
Why?
|
| Risk Factors | 4 | 2013 | 4984 | 0.090 |
Why?
|
| Age Factors | 2 | 2014 | 1504 | 0.090 |
Why?
|
| beta 2-Microglobulin | 1 | 2011 | 48 | 0.090 |
Why?
|
| Health Resources | 1 | 2012 | 87 | 0.090 |
Why?
|
| Nutrition Policy | 1 | 2011 | 39 | 0.090 |
Why?
|
| Phosphatidylserines | 1 | 2010 | 13 | 0.090 |
Why?
|
| Program Development | 1 | 2012 | 203 | 0.090 |
Why?
|
| Community Health Services | 1 | 2011 | 120 | 0.090 |
Why?
|
| alpha-Tocopherol | 3 | 2004 | 18 | 0.090 |
Why?
|
| Depression | 1 | 2017 | 828 | 0.090 |
Why?
|
| Fruit | 2 | 2001 | 104 | 0.080 |
Why?
|
| Glycemic Index | 1 | 2009 | 22 | 0.080 |
Why?
|
| Capillaries | 1 | 2009 | 30 | 0.080 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2000 | 47 | 0.080 |
Why?
|
| Time Factors | 4 | 2019 | 3617 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 2337 | 0.080 |
Why?
|
| Water Purification | 1 | 2009 | 5 | 0.080 |
Why?
|
| Filtration | 1 | 2009 | 20 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2010 | 260 | 0.080 |
Why?
|
| Triglycerides | 4 | 2006 | 231 | 0.080 |
Why?
|
| Rats | 5 | 2007 | 1910 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 1561 | 0.080 |
Why?
|
| Linoleic Acid | 2 | 2004 | 18 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2008 | 555 | 0.080 |
Why?
|
| Body Composition | 1 | 2009 | 146 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 446 | 0.080 |
Why?
|
| Epoetin Alfa | 1 | 2008 | 2 | 0.080 |
Why?
|
| Hematinics | 1 | 2008 | 10 | 0.070 |
Why?
|
| Glucaric Acid | 1 | 2007 | 2 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2008 | 43 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2008 | 589 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 1988 | 132 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 166 | 0.070 |
Why?
|
| Glycosaminoglycans | 1 | 2007 | 18 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 155 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2008 | 244 | 0.070 |
Why?
|
| Age Distribution | 1 | 2008 | 249 | 0.070 |
Why?
|
| Health Promotion | 1 | 2011 | 471 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 115 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2007 | 120 | 0.070 |
Why?
|
| Hemodialysis Solutions | 1 | 2006 | 2 | 0.070 |
Why?
|
| Linear Models | 1 | 2008 | 402 | 0.070 |
Why?
|
| Calcium, Dietary | 1 | 2006 | 29 | 0.070 |
Why?
|
| Long-Term Care | 1 | 2008 | 176 | 0.070 |
Why?
|
| Cholesterol Esters | 3 | 2004 | 10 | 0.070 |
Why?
|
| Thioctic Acid | 2 | 1997 | 7 | 0.060 |
Why?
|
| Oral Health | 1 | 2006 | 61 | 0.060 |
Why?
|
| Indicator Dilution Techniques | 2 | 1997 | 3 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2008 | 206 | 0.060 |
Why?
|
| Lipid Peroxidation | 3 | 2001 | 63 | 0.060 |
Why?
|
| Indicators and Reagents | 2 | 1998 | 51 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2006 | 95 | 0.060 |
Why?
|
| Body Temperature | 1 | 2005 | 45 | 0.060 |
Why?
|
| Liver | 3 | 1998 | 797 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1999 | 806 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 635 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 30 | 0.060 |
Why?
|
| Oleic Acid | 1 | 2004 | 21 | 0.060 |
Why?
|
| Aging | 4 | 2006 | 710 | 0.060 |
Why?
|
| Incidence | 1 | 2008 | 1237 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 47 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2004 | 72 | 0.050 |
Why?
|
| Croton Oil | 1 | 2003 | 1 | 0.050 |
Why?
|
| Plant Oils | 2 | 2004 | 56 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2001 | 582 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 555 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2008 | 1921 | 0.050 |
Why?
|
| Oxidants | 2 | 2000 | 18 | 0.050 |
Why?
|
| Arginine | 1 | 2003 | 110 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1479 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 1025 | 0.050 |
Why?
|
| Vegetables | 2 | 2001 | 66 | 0.050 |
Why?
|
| Esterification | 2 | 2001 | 4 | 0.050 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2003 | 44 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2022 | 17 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2005 | 359 | 0.050 |
Why?
|
| Tanzania | 2 | 2012 | 19 | 0.050 |
Why?
|
| Infant | 2 | 2020 | 1486 | 0.050 |
Why?
|
| Skin | 1 | 2005 | 357 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 677 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 450 | 0.050 |
Why?
|
| Acute-Phase Reaction | 1 | 2001 | 18 | 0.050 |
Why?
|
| Food, Organic | 1 | 2001 | 4 | 0.050 |
Why?
|
| Diet, Fat-Restricted | 1 | 2001 | 33 | 0.050 |
Why?
|
| Spectrophotometry | 2 | 1992 | 35 | 0.050 |
Why?
|
| Isomerism | 2 | 2020 | 28 | 0.050 |
Why?
|
| Cholesterol, Dietary | 1 | 2001 | 28 | 0.050 |
Why?
|
| Models, Biological | 1 | 2006 | 1143 | 0.050 |
Why?
|
| Glutathione | 2 | 1998 | 54 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2013 | 6071 | 0.050 |
Why?
|
| Deuterium | 3 | 1998 | 24 | 0.050 |
Why?
|
| Diterpenes | 3 | 1998 | 19 | 0.050 |
Why?
|
| Acetylation | 1 | 2000 | 113 | 0.040 |
Why?
|
| Pentanes | 1 | 2000 | 2 | 0.040 |
Why?
|
| Cricetulus | 1 | 2020 | 99 | 0.040 |
Why?
|
| Butylated Hydroxytoluene | 1 | 1999 | 4 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 129 | 0.040 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1999 | 19 | 0.040 |
Why?
|
| Membrane Fluidity | 1 | 1999 | 14 | 0.040 |
Why?
|
| Cytokines | 1 | 2004 | 912 | 0.040 |
Why?
|
| gamma-Linolenic Acid | 1 | 1999 | 16 | 0.040 |
Why?
|
| CHO Cells | 1 | 2020 | 189 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2000 | 292 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2017 | 831 | 0.040 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2019 | 12 | 0.040 |
Why?
|
| Macular Degeneration | 1 | 2001 | 178 | 0.040 |
Why?
|
| Cryptoxanthins | 2 | 1996 | 2 | 0.040 |
Why?
|
| Vitamin A Deficiency | 1 | 1998 | 3 | 0.040 |
Why?
|
| Phenylhydrazines | 1 | 1998 | 1 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 1 | 1998 | 1 | 0.040 |
Why?
|
| Diamide | 1 | 1998 | 6 | 0.040 |
Why?
|
| Trypsin | 1 | 1998 | 39 | 0.040 |
Why?
|
| Plant Extracts | 1 | 1999 | 163 | 0.040 |
Why?
|
| Ligases | 1 | 1998 | 26 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1998 | 41 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1998 | 184 | 0.040 |
Why?
|
| Hydrolysis | 1 | 1998 | 140 | 0.040 |
Why?
|
| Aqueous Humor | 1 | 1997 | 4 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 1997 | 15 | 0.040 |
Why?
|
| Biomarkers | 2 | 2000 | 1306 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 1093 | 0.030 |
Why?
|
| Exercise | 3 | 2011 | 883 | 0.030 |
Why?
|
| NADP | 1 | 1997 | 22 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1998 | 1952 | 0.030 |
Why?
|
| NAD | 1 | 1997 | 50 | 0.030 |
Why?
|
| Cricetinae | 3 | 2004 | 366 | 0.030 |
Why?
|
| Cytosol | 1 | 1997 | 171 | 0.030 |
Why?
|
| Administration, Oral | 4 | 1997 | 356 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2001 | 1189 | 0.030 |
Why?
|
| Free Radicals | 2 | 1995 | 18 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1782 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 1554 | 0.030 |
Why?
|
| Saimiri | 2 | 1991 | 11 | 0.030 |
Why?
|
| Densitometry | 2 | 1991 | 12 | 0.030 |
Why?
|
| Macaca fascicularis | 2 | 1991 | 46 | 0.030 |
Why?
|
| Mesocricetus | 2 | 2004 | 93 | 0.030 |
Why?
|
| Mitochondria | 1 | 1997 | 343 | 0.030 |
Why?
|
| Physical Exertion | 1 | 1992 | 79 | 0.020 |
Why?
|
| Chromobacterium | 1 | 1992 | 1 | 0.020 |
Why?
|
| Pseudomonas | 1 | 1992 | 7 | 0.020 |
Why?
|
| Sterol Esterase | 1 | 1992 | 6 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 1992 | 11 | 0.020 |
Why?
|
| Haplorhini | 1 | 1992 | 14 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1989 | 90 | 0.020 |
Why?
|
| Solvents | 1 | 1992 | 57 | 0.020 |
Why?
|
| Kidneys, Artificial | 1 | 2011 | 1 | 0.020 |
Why?
|
| Lipase | 1 | 1992 | 48 | 0.020 |
Why?
|
| Neoplasms | 1 | 2001 | 1240 | 0.020 |
Why?
|
| Charcoal | 1 | 2011 | 5 | 0.020 |
Why?
|
| Tissue Preservation | 1 | 1991 | 5 | 0.020 |
Why?
|
| Fixatives | 1 | 1991 | 17 | 0.020 |
Why?
|
| Adsorption | 1 | 2011 | 82 | 0.020 |
Why?
|
| Sodium Hypochlorite | 1 | 1991 | 12 | 0.020 |
Why?
|
| Biotechnology | 1 | 2011 | 42 | 0.020 |
Why?
|
| Chemistry | 2 | 1988 | 31 | 0.020 |
Why?
|
| Chemical Phenomena | 2 | 1988 | 94 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 2003 | 157 | 0.020 |
Why?
|
| Hemochromatosis | 1 | 1990 | 6 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1990 | 17 | 0.020 |
Why?
|
| Ferritins | 1 | 1990 | 30 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1990 | 93 | 0.020 |
Why?
|
| Life Style | 1 | 2011 | 299 | 0.020 |
Why?
|
| Genes | 1 | 1990 | 90 | 0.020 |
Why?
|
| Poverty | 1 | 2011 | 281 | 0.020 |
Why?
|
| Weight Loss | 1 | 2011 | 263 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 741 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2513 | 0.020 |
Why?
|
| Arm | 1 | 2009 | 42 | 0.020 |
Why?
|
| Potassium | 1 | 2009 | 100 | 0.020 |
Why?
|
| Linoleic Acids | 1 | 1988 | 8 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2011 | 392 | 0.020 |
Why?
|
| Health Behavior | 1 | 2011 | 451 | 0.020 |
Why?
|
| Kidney | 2 | 2003 | 416 | 0.020 |
Why?
|
| Epidemiologic Factors | 1 | 2007 | 4 | 0.020 |
Why?
|
| Adolescent | 3 | 2012 | 5824 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 287 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2007 | 80 | 0.020 |
Why?
|
| Photometry | 1 | 2006 | 7 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2007 | 133 | 0.020 |
Why?
|
| Biopsy | 1 | 1988 | 411 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1998 | 574 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2006 | 74 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 153 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2007 | 146 | 0.020 |
Why?
|
| Retinaldehyde | 1 | 1985 | 1 | 0.020 |
Why?
|
| Oximes | 1 | 1985 | 11 | 0.020 |
Why?
|
| Retinoids | 1 | 1985 | 12 | 0.020 |
Why?
|
| Massachusetts | 1 | 2011 | 2002 | 0.020 |
Why?
|
| Forecasting | 1 | 2006 | 219 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1985 | 22 | 0.020 |
Why?
|
| Skin Temperature | 1 | 2005 | 18 | 0.020 |
Why?
|
| Phospholipases | 1 | 1985 | 9 | 0.010 |
Why?
|
| Peroxides | 1 | 1985 | 11 | 0.010 |
Why?
|
| Phospholipases A | 1 | 1985 | 11 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 1985 | 27 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 108 | 0.010 |
Why?
|
| Sunflower Oil | 1 | 2004 | 5 | 0.010 |
Why?
|
| Olive Oil | 1 | 2004 | 7 | 0.010 |
Why?
|
| Phospholipids | 1 | 1985 | 78 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2005 | 230 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 108 | 0.010 |
Why?
|
| Dromaiidae | 1 | 2003 | 1 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 81 | 0.010 |
Why?
|
| Ear, External | 1 | 2003 | 6 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2003 | 47 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 179 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 164 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 1999 | 715 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1998 | 2093 | 0.010 |
Why?
|
| Amino Acids, Sulfur | 1 | 1982 | 1 | 0.010 |
Why?
|
| Chromium | 1 | 1982 | 4 | 0.010 |
Why?
|
| Vitamin E Deficiency | 1 | 1982 | 9 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 4267 | 0.010 |
Why?
|
| Serum Amyloid A Protein | 1 | 2001 | 7 | 0.010 |
Why?
|
| ROC Curve | 1 | 2001 | 266 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 588 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 914 | 0.010 |
Why?
|
| Scintillation Counting | 1 | 1999 | 2 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1999 | 15 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 2060 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1999 | 63 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 68 | 0.010 |
Why?
|
| Seeds | 1 | 1999 | 31 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1999 | 44 | 0.010 |
Why?
|
| Respiration | 1 | 2000 | 88 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1999 | 164 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 48 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 238 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 1998 | 2 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1998 | 17 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 98 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1998 | 48 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1997 | 102 | 0.010 |
Why?
|
| Bangladesh | 1 | 1997 | 19 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 88 | 0.010 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 1 | 1997 | 2 | 0.010 |
Why?
|
| Glutathione Reductase | 1 | 1997 | 5 | 0.010 |
Why?
|
| Abdomen | 1 | 1997 | 91 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1997 | 485 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1995 | 7 | 0.010 |
Why?
|
| Aldehydes | 1 | 1995 | 16 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1997 | 333 | 0.010 |
Why?
|
| Potentiometry | 1 | 1995 | 1 | 0.010 |
Why?
|
| Myocardium | 1 | 1997 | 264 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1996 | 441 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 1993 | 13 | 0.010 |
Why?
|
| Uric Acid | 1 | 1993 | 45 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1995 | 377 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1992 | 16 | 0.010 |
Why?
|
| Food Analysis | 1 | 1990 | 31 | 0.010 |
Why?
|
| Zea mays | 1 | 1990 | 22 | 0.010 |
Why?
|
| Cell Line | 1 | 1995 | 1984 | 0.010 |
Why?
|
| Species Specificity | 1 | 1991 | 329 | 0.010 |
Why?
|
| Pseudogenes | 1 | 1990 | 12 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1990 | 16 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1990 | 52 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 51 | 0.010 |
Why?
|
| Proteins | 1 | 1995 | 730 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1995 | 986 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 111 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1990 | 374 | 0.010 |
Why?
|
| Mice | 1 | 2003 | 10292 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1990 | 284 | 0.000 |
Why?
|
| Brain | 1 | 1997 | 1488 | 0.000 |
Why?
|
| Base Sequence | 1 | 1990 | 1302 | 0.000 |
Why?
|
| Phenotype | 1 | 1991 | 1137 | 0.000 |
Why?
|
| Tocopherols | 1 | 1986 | 10 | 0.000 |
Why?
|
| Epithelium | 1 | 1985 | 96 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 192 | 0.000 |
Why?
|
| DNA | 1 | 1990 | 806 | 0.000 |
Why?
|
| Phospholipases A2 | 1 | 1985 | 12 | 0.000 |
Why?
|
| Biological Availability | 1 | 1986 | 195 | 0.000 |
Why?
|
| Colorimetry | 1 | 1985 | 24 | 0.000 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1982 | 12 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1982 | 247 | 0.000 |
Why?
|